Arcturus Therapeutics

06/11/2026

Registration is now open for the FREE virtual Urea Cycle Disorders: The Rhythm of Progress Symposium on Friday, July 17, 2026.

This full-day symposium will bring together clinicians, researchers, trainees, and healthcare professionals dedicated to advancing care for individuals with urea cycle disorders (UCDs).

Families are welcome to attend virtually. Please note that presentations will be primarily scientific and clinical in nature and may include technical language.

Learn more here: https://nucdf.org/news-and-events/events/

06/09/2026

☀️ Longer days, familiar faces. Summer brings change, but support stays steady. CFRI’s online Support Groups meet monthly and welcome participants from around the world. Connection that fits into your life, wherever you are.

👉🏽 Register: https://www.cfri.org/education-support/psychosocial-support-programs/

CFRI support groups are made possible in 2026 to date by Viatris, Genentech, individual donors and bequests.

06/03/2026

Learn about Arcturus' approach to treating cystic fibrosis (CF). CF is a genetic disease that affects approximately 100,000 people worldwide and over 30,000 people in the US. It's caused by mutations in the cystic fibrosis transmembrane regulator gene (CFTR). Learn how this investigational mRNA therapy targets the root cause of CF by restoring the CFTR protein.

https://www.youtube.com/watch?v=qAJlUL7A0vI

To learn about Arcturus’ investigational mRNA treatment, LUNAIR CF for CF, visit: LUNARCF.com or ClinicalTrials.gov (NCT06747858).

Learn about Arcturus' approach to treating cystic fibrosis (CF). CF...

05/28/2026

Last week, we presented our poster at the Society for Inherited Metabolic Disorders (SIMD) 2026 Annual Meeting.

Missed us in person? Please see below or go tohttps://arcturusrx.com/wp-content/uploads/2026/05/SIMD-Poster-INTERIM-RESULTS-OF-PHASE-2-TRIAL-OF-ARCT-810-mRNA-THERAPY-IN-PATIENTS-WITH-2026-vFinal.pdf

05/27/2026

Join Emily’s Entourage for a free, informational webinar on the mRNA approach and LunairCF clinical trial from Arcturus Therapeutics.

The Arcturus team will share an overview of the mRNA approach to therapy, including the currently enrolling LunairCF study of an investigational mRNA therapy for the treatment of CF lung disease. They’ll also answer live and pre-submitted questions from the audience, and EE will share about our CF Clinical Trial Connect database and clinical trial matchmaking program.

🗓 Monday, June 8
🕖 7:00–8:00 PM ET

The event is free, but registration is required in advance. Individuals with CF, family members, caregivers, healthcare providers, researchers, and other members of the CF community are all welcome to attend.

👉 REGISTER >> https://us02web.zoom.us/webinar/register/WN_nAz6bFJSS0mI_NjCdJSKnQ #/registration

05/26/2026

While groundbreaking therapies have transformed care for about 90% of people with , about 10% do not benefit from current mutation-targeted treatments.

That means thousands of people are still waiting.

Waiting for breakthroughs.

Waiting for relief. Waiting for more time.

No one should be left behind.



💜 Share this fact to help accelerate awareness and for everyone.

05/20/2026

💐 Support is always in season. During CF Awareness Month, we’re reminded how powerful community can be. CFRI’s monthly online Support Groups provide peer-to-peer connection led by experienced facilitators.
Come as you are. Stay as long as you need.

Register: https://www.cfri.org/education-support/psychosocial-support-programs/

CFRI support groups are made possible in 2026 to date by Viatris, Genentech, individual donors and bequests.

05/18/2026

Are you attending the Society for Inherited Metabolic Disorders 2026 Annual Meeting?

Stop by our poster, Poster #52, to learn more about our OTC Deficiency program.

05/14/2026

Caring for someone with a rare condition can reshape how we show up for ourselves and each other.

We’re happy to share a Mental Health Toolkit developed by Give an Hour, offering practical, trauma-informed tools to support patients & caregivers navigating stress, connection, and resilience.

🔗 Explore the toolkit: https://giveanhour.org/tools/

Give an Hour is committed to creating resilient individuals & communities. Education, through this resource library, is part of that goal.

05/13/2026

People with spend hours each day doing airway clearance—often doing breathing treatments to open their airways and using a therapy vest that inflates and shakes to help move mucus in their lungs.

According to Emily's Entourage's Final 10% Survey, 70.4% of adults with spend 1–4 hours every day on treatments. 🤯

That’s up to 25% of waking hours spent tethered to medical treatments—just to breathe!!!

This is why speeding lifesaving breakthroughs matter—and why we’re working urgently to …once and for all.

📖 Read more:https://www.emilysentourage.org/wp-content/uploads/ee-final-10-percent-survey.pdf


💜 Share to spread awareness this